university website

E.G. Kamburova, B.W. Wisse, I. Joosten (Irma), W.A. Allebes (Wil), A. van der Meer, L.B. Hilbrands (Luuk), M.C. Baas (Marije), E. Spierings (E.), C.E. Hack (Erik), F. van Reekum, et al. van Zuilen, A.D. (A. D.), M.C. Verhaar (Marianne), Bots, M.L. (M. L.), A.C.A.D. Drop, L. Plaisier, M.A.J. Seelen, J.S.F. Sanders, B.G. Hepkema (Bouke), A.J.A. Lambeck (Annechien J.A.), L.B. Bungener, C. Roozendaal, M.G.J. Tilanus (Marcel), C.E.M. Voorter (C. E M), L. Wieten, E. van Duijnhoven, M. Gelens, M.H. Christiaans (Maarten), F. van Ittersum, S.A. Nurmohamed (Shaikh Azam), N.M. Lardy (Neubury), W.T. Swelsen, K.A. van der Pant, N.C. van der Weerd (Neelke), I.J.M. ten Berge (Ineke), F.J. Bemelman (Fréderike), A.J. Hoitsma (Andries), P.J.M. van der Boog, J.W. de Fijter (Johan), M.G.H. Betjes (Michiel), P.J. Heidt (Peter), D.L. Roelen (Dave), F.H.J. Claas (Frans) and H.G. Otten (Henderikus)

2018-09-01

Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant

Publication

Publication

American Journal of Transplantation , Volume 18 - Issue 9 p. 2274- 2284

The presence of donor-specific anti-HLA antibodies (DSAs) is associated with increased risk of graft failure after kidney transplant. We hypothesized that DSAs against HLA class I, class II, or both classes indicate a different risk for graft loss between deceased and living donor transplant. In this study, we investigated the impact of pretransplant DSAs, by using single antigen bead assays, on long-term graft survival in 3237 deceased and 1487 living donor kidney transplants with a negative complement-dependent crossmatch. In living donor transplants, we found a limited effect on graft survival of DSAs against class I or II antigens after transplant. Class I and II DSAs combined resulted in decreased 10-year graft survival (84% to 75%). In contrast, after deceased donor transplant, patients with class I or class II DSAs had a 10-year graft survival of 59% and 60%, respectively, both significantly lower than the survival for patients without DSAs (76%). The combination of class I and II DSAs resulted in a 10-year survival of 54% in deceased donor transplants. In conclusion, class I and II DSAs are a clear risk factor for graft loss in deceased donor transplants, while in living donor transplants, class I and II DSAs seem to be associated with an increased risk for graft failure, but this could not be assessed due to their low prevalence.

Additional Metadata
Keywords alloantibody, clinical research/practice, graft survival, kidney failure/injury, kidney transplantation, kidney transplantation/nephrology, living donor
Persistent URL doi.org/10.1111/ajt.14709, hdl.handle.net/1765/114331
Journal American Journal of Transplantation
Organisation Erasmus MC: University Medical Center Rotterdam
Citation
Kamburova, E.G, Wisse, B.W, Joosten, I, Allebes, W.A, van der Meer, A, Hilbrands, L.B, … Otten, H.G. (2018). Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant. American Journal of Transplantation, 18(9), 2274–2284. doi:10.1111/ajt.14709
Free Full Text ( Final Version , 889kb ) cover


User Publication Person Organisation Collection
Close